Northwest Biotherapeutics, Inc. (NWBO)
0.1537
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Northwest Biotherapeutics Profit Margin (Quarterly) : -1.14K% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.14K% |
| March 31, 2026 | -621.3% |
| December 31, 2025 | |
| September 30, 2025 | -13.41K% |
| June 30, 2025 | -11.74K% |
| March 31, 2025 | -5.16K% |
| December 31, 2024 | -12.22K% |
| September 30, 2024 | -5.43K% |
| June 30, 2024 | -3.50K% |
| March 31, 2024 | -6.45K% |
| December 31, 2023 | -4.25K% |
| September 30, 2023 | -4.58K% |
| June 30, 2023 | -7.19K% |
| March 31, 2023 | -1.21K% |
| December 31, 2022 | -4.74K% |
| September 30, 2022 | -15.95K% |
| June 30, 2022 | -6.22K% |
| March 31, 2022 | -3.53K% |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | -1.73K% |
| December 31, 2020 | -55.73K% |
| September 30, 2020 | -89.86K% |
| June 30, 2020 | -2.90M% |
| Date | Value |
|---|---|
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | -1.07K% |
| June 30, 2019 | 37.69% |
| March 31, 2019 | -6.18K% |
| September 30, 2018 | |
| June 30, 2018 | -7.62K% |
| March 31, 2018 | -16.32K% |
| December 31, 2017 | -84.37K% |
| September 30, 2017 | -15.72K% |
| June 30, 2017 | -11.65K% |
| March 31, 2017 | -18.56K% |
| December 31, 2016 | -43.25K% |
| September 30, 2016 | -20.27K% |
| June 30, 2016 | -10.71K% |
| March 31, 2016 | -2.59K% |
| December 31, 2015 | -2.79K% |
| September 30, 2015 | |
| June 30, 2015 | -17.10K% |
| March 31, 2015 | -23.93K% |
| December 31, 2014 | -4.90K% |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| Savara, Inc. | -- |
| Vericel Corp. | 2.85% |
| Biogen, Inc. | 3.72% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -32.39% |
| Return on Invested Capital | -417.1% |
| Gross Profit Margin (Quarterly) | -5.58% |
| Operating Margin (Quarterly) | -1.44K% |
| Return on Net Operating Assets | -70.39% |